Altered adenosine-to-inosine RNA editing in human cancer

Genome Research - Tập 17 Số 11 - Trang 1586-1595 - 2007
Nurit Paz1, Erez Y. Levanon2,3, Ninette Amariglio4,5, Amy B. Heimberger6, Zvi Ram7, Shlomi Constantini7, Zohar Barbash4,5, Konstantin Adamsky4, Michal Safran4,5, Avi Hirschberg4,5, Meir Krupsky4,8, Issachar Ben-Dov4,8, Simona Cazacu9, Tom Mikkelsen9, Chaya Brodie9,10, Eli Eisenberg5, Gideon Rechavi11
1Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel
2Compugen Ltd.
3Harvard University
4Sheba Medical Center At Tel Hashomer
5Tel-Aviv University
6UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER
7Tel-Aviv Sourasky Medical Center;
8Tel Aviv University
9Henry Ford Health System
10NATIONAL INSTITUTES OF HEALTH
11Cancer Research Center

Tóm tắt

Adenosine-to-inosine (A-to-I) RNA editing was recently shown to be abundant in the human transcriptome, affecting thousands of genes. Employing a bioinformatic approach, we identified significant global hypoediting of Alu repetitive elements in brain, prostate, lung, kidney, and testis tumors. Experimental validation confirmed this finding, showing significantly reduced editing in Alu sequences within MED13 transcripts in brain tissues. Looking at editing of specific recoding and noncoding sites, including in cancer-related genes, a more complex picture emerged, with a gene-specific editing pattern in tumors vs. normal tissues. Additionally, we found reduced RNA levels of all three editing mediating enzymes, ADAR, ADARB1, and ADARB2, in brain tumors. The reduction of ADARB2 correlated with the grade of malignancy of glioblastoma multiforme, the most aggressive of brain tumors, displaying a 99% decrease in ADARB2 RNA levels. Consistently, overexpression of ADAR and ADARB1 in the U87 glioblastoma multiforme cell line resulted in decreased proliferation rate, suggesting that reduced A-to-I editing in brain tumors is involved in the pathogenesis of cancer. Altered epigenetic control was recently shown to play a central role in oncogenesis. We suggest that A-to-I RNA editing may serve as an additional epigenetic mechanism relevant to cancer development and progression.

Từ khóa


Tài liệu tham khảo

10.1371/journal.pbio.0020391

10.1146/annurev.biochem.71.110601.135501

10.1200/JCO.2005.16.600

10.1101/gr.2951204

10.1186/gb-2006-7-4-r27

Boulton,, 2006, BRCA1-mediated ubiquitylation, Cell Cycle, 5, 1481, 10.4161/cc.5.14.2930

Brusa,, 1995, Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice, Science, 270, 1677, 10.1126/science.270.5242.1677

10.1038/sj.onc.1208652

10.1017/S1355838200000170

10.1158/0008-5472.CAN-04-4243

10.1093/bioinformatics/bti411

10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W

10.1016/j.tig.2004.12.005

10.1038/301089a0

10.1038/nrg1748

10.1016/j.cub.2005.02.012

10.1016/j.immuni.2006.03.021

10.1002/ijc.10244

10.1016/S0896-6273(02)00660-8

10.1074/jbc.M311347200

10.1038/35017558

10.1038/427801a

10.1101/gr.2855504

10.1038/nbt996

10.1093/nar/gki239

10.1038/sj.embor.7400507

10.1073/pnas.0736237100

10.1038/nature03702

10.1261/rna.7350304

10.1073/pnas.251531398

10.1073/pnas.091582298

10.1261/rna.165106

10.1128/JVI.01527-06

10.1016/S0092-8674(00)00049-0

Patterson,, 1995, Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: Evidence for two forms of the deaminase, Mol. Cell. Biol., 15, 5376, 10.1128/MCB.15.10.5376

10.1016/j.cell.2005.08.033

10.1002/1097-0215(20001201)88:5<726::AID-IJC7>3.0.CO;2-H

Sardi,, 1997, Abnormal c-myc oncogene DNA methylation in human bladder cancer: Possible role in tumor progression, Eur. Urol., 31, 224, 10.1159/000474455

10.1093/nar/gki909

10.1016/S0896-6273(03)00354-4

10.1016/j.tig.2006.08.007

Su,, 2003, Relationship between expression of BLCAP protein and malignancy of osteosarcoma, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 19, 465

10.1073/pnas.0400782101

10.1126/science.1091340

10.1126/science.290.5497.1765

10.1093/hmg/10.7.705

10.1073/pnas.92.18.8483

10.1038/nsmb1041

10.1007/s11010-006-9332-2